|Articles|March 1, 1997

Integrating Risk Factor Management of Coronary Heart Disease into Managed Care
Volume 3
Issue 3 Suppl

Applying Lipid Clinical Trials to the Practical Management of High-Risk Patients

Download PDF: Applying Lipid Clinical Trials to the Practical Management of High-Risk Patients

Articles in this issue

over 29 years ago

Article

Goals and Objectives

over 29 years ago

Article

Introduction

over 29 years ago

Article

Integrating Risk Factor Management into the Care of the Cardiac Patient

over 29 years ago

Article

Risk-Factor Management in Women and Other Special Patients

over 29 years ago

Article

Clinical Implications of Recent Cholesterol Lowering Trials for the Secondary Prevention of Coronary Heart Disease

over 29 years ago

Article

Risk Factor Management: Exploring the Boundaries

over 29 years ago

Article

CME Quiz

over 29 years ago

Article

Bibliography

over 29 years ago

Article

Converting Clinical Lipid Trials into the Practical Management of High-Risk Patients: New NECP Thoughts on Treating CHD Patients

over 29 years ago

Article

Review of the NIH Post-CABG Study and Future Advances in HMG-CoA Therapy

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Applying Lipid Clinical Trials to the Practical Management of High-Risk Patients

Articles in this issue

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Trending on AJMC

FDA Panel Backs 6 Peptides for Compounding

Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%

FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies

Study Shows Potential for Low-Dose CAR T, With Implications for Increased Access